# Investor Pitch — NeuroBleed Alert

> Intracranial Hemorrhage Detection · AI-Powered · Wearable · Real-Time

---

## Problem

**Intracranial hemorrhage (ICH) is the most lethal neurological emergency — and current monitoring misses it until it's too late.**

- **67%** of ICH patients deteriorate within 6 hours of admission
- **50%** of in-hospital ICH deaths are potentially preventable with earlier detection
- Current monitoring: Nurse checks Q30min, vital signs only, **no cerebral oxygen data**
- Average time from physiological deterioration to clinical recognition: **4+ hours**
- Each hour of delayed intervention increases mortality by **~15%**

> "By the time the vitals change, the brain has been ischemic for hours."

---

## Solution

**NeuroBleed Alert**: The first end-to-end, AI-powered wearable system for continuous ICH monitoring.

```
┌───────────────────────────────────────────────────────────┐
│                    HOW IT WORKS                            │
│                                                           │
│  [Wearable Sensor] ─BLE─► [Flutter App] ──► [Cloud AI]   │
│   • rSO2 (brain O2)         • Real-time vitals    • Risk  │
│   • HR, SpO2, BP           • AI alerts            • Score │
│   • Motion detection       • Offline support       • SHAP │
│   • 14-day battery         • Arabic/English        │      │
│                                                           │
│  ┌──────────────────── ALERT ────────────────────────┐   │
│  │  ⚠️ CRITICAL: ICH SUSPECTED — Patient: #4421     │   │
│  │  Risk Score: 0.89  ▲ 15% in 5 min                │   │
│  │  Drivers: rSO2 ↓ 18%, HR ↑ 40, MAP ↑ 25         │   │
│  │  [Acknowledge]  [View Patient]  [Call Team]     │   │
│  └──────────────────────────────────────────────────┘   │
└───────────────────────────────────────────────────────────┘
```

**Key Differentiator**: 10× cheaper than ICU monitors, ICH-specific (not generic), AI-native with explainability.

---

## Market Opportunity

| Metric | Value |
|--------|-------|
| **TAM** (Global ICH Monitoring) | $5B |
| **SAM** (MENA) | $500M |
| **SOM** (Year 1–3) | $30M |
| **Target Customers** | 500+ hospitals in KSA/UAE/EGY |
| **Growth Rate** | 12% CAGR (AI health monitoring) |

**MENA Context**: Saudi Vision 2030 has allocated **$65B+** to healthcare digitization. There are **0** ICH-specific AI monitoring solutions in the MENA market.

---

## Technology

| Component | Stack | Status |
|-----------|-------|--------|
| Mobile App | Flutter (Android, iOS, Web) | ✅ Built |
| Backend API | FastAPI (Python) | ✅ Built |
| Database | PostgreSQL + Redis + Isar | ✅ Built |
| AI Engine | XGBoost ensemble + SHAP | ⬜ Training |
| Hardware | ESP32-S3 + NIRS sensors | ⬜ Frozen |
| Localization | Arabic/English, RTL/LTR | ✅ Built |
| Architecture | Multi-tenant, Clean Architecture | ✅ Built |
| DevOps | Docker, CI/CD, GitHub Actions | ✅ Built |

**Unique Technical Advantages**:
- Offline-first with Isar (sync when connected)
- AI risk score with SHAP explanations (no black box)
- Multi-tenant by design (hospital chains ready)
- Sub-5-second alert latency (BLE → Cloud → Mobile)

---

## Business Model

| Stream | Model | Target (Year 1) |
|--------|-------|-----------------|
| Hospital Subscription | $200–500/bed/month | $192K |
| Device Hardware | $2,500/unit | $75K |
| Total Revenue (Year 1) | | **~$267K** |
| Total Revenue (Year 3) | | **~$5.75M** |

**Unit Economics**: LTV ~$120K per hospital / CAC ~$15K = **8:1 LTV/CAC ratio**.

---

## Competitive Advantage

| Advantage | Description | Moat |
|-----------|-------------|------|
| **ICH Focus** | Not a generic monitor — purpose-built for ICH | Deep |
| **AI Native** | XGBoost + SHAP from day one | Medium |
| **MENA First** | Arabic/RTL full support, local partnerships | Deep |
| **Cost** | 10× cheaper than Philips/GE ICU monitors | Medium |
| **Offline** | Works without internet — critical for ICUs | Medium |
| **Multi-tenant** | Hospital chain deployment ready | Medium |

---

## Roadmap

```
2026 Q3–Q4:  Software Platform Complete
              Backend + Flutter + AI Engine
              ↓
2027 Q1:      Hospital Pilots (3 hospitals, KSA)
              Clinical Validation Study
              ↓
2027 Q2–Q3:  SFDA Registration
              First Paid Contracts
              Series A Fundraising
              ↓
2027 Q4:      UAE + Egypt Expansion
              50 Hospitals Target
              ↓
2028:         FDA 510(k) Application
              US Market Entry
              Global Expansion
```

---

## The Ask

**Raising**: $2M Seed Round (18-month runway)

**Use of Funds**:
- Engineering (8 FTEs) — $800K
- Hardware Development — $400K
- Clinical Validation — $200K
- Regulatory (FDA/SFDA) — $200K
- Sales & Marketing — $200K
- Operations — $200K

---

## Team

| Role | Background |
|------|-----------|
| **CEO / Product** | Medical device experience, MENA healthcare |
| **CTO** | Full-stack + AI (Flutter, FastAPI, XGBoost) |
| **Hardware Lead** | Embedded systems, ESP32, BLE |
| **Clinical Advisor** | Neurosurgeon, KSA hospital |

---

## Contact

**NeuroBleed Alert** — Saving Brains, One Alert at a Time.
